Methodology of the health economic evaluation of the Feel4Diabetes-study

Willems, R. ; Pil, L. ; Lambrinou, C.P. ; Kivelä, J. ; Wikström, K. ; Gonzalez-Gil, E.M. ; De Miguel-Etayo, P. ; Nánási, A. ; Semánová, C. ; Van Stappen, V. ; Cardon, G. ; Tsochev, K. ; Iotova, V. ; Chakarova, N. ; Makrilakis, K. ; Dafoulas, G. ; Timpel, P. ; Schwarz, P. ; Manios, Y. ; Annemans, L. ; Feel4Diabetes, research, group

Resumen: BACKGROUND: The clinical and economic burden of type 2 diabetes mellitus on society is rising. Effective and efficient preventive measures may stop the increasing prevalence, given that type 2 diabetes mellitus is mainly a lifestyle-driven disease. The Feel4Diabetes-study aimed to tackle unhealthy lifestyle (unhealthy diet, lack of physical activity, sedentary behaviour, and excess weight) of families with a child in the first grades of elementary school. These schools were located in regions with a relatively low socio-economic status in Belgium, Bulgaria, Finland, Greece, Hungary and Spain. Special attention was paid to families with a high risk of developing type 2 diabetes mellitus. METHODS: The aim of this paper is to describe the detailed methodology of the intervention''s cost-effectiveness analysis. Based on the health economic evaluation of the Toybox-study, both a decision analytic part and a Markov model have been designed to assess the long-term (time horizon of 70¿year with one-year¿cycles) intervention''s value for money. Data sources used for the calculation of health state incidences, transition probabilities between health states, health state costs, and health state utilities are listed. Intervention-related costs were collected by questionnaires and diaries, and attributed to either all families or high risk families only. CONCLUSIONS: The optimal use of limited resources is pivotal. The future results of the health economic evaluation of the Feel4Diabetes-study will contribute to the efficient use of those resources.

Idioma: Inglés

DOI: 10.1186/s12902-019-0471-3

Año: 2020

Publicado en: BMC endocrine disorders 20, Supl 1 (2020), 14 [11 pp.]
ISSN: 1472-6823

Factor impacto JCR: 2.763 (2020)

Categ. JCR: ENDOCRINOLOGY & METABOLISM rank: 110 / 145 = 0.759 (2020) - Q4 - T3

Factor impacto SCIMAGO: 0.743 - Medicine (miscellaneous) (Q2) - Endocrinology, Diabetes and Metabolism (Q2)

Financiación: info:eu-repo/grantAgreement/EC/H2020/643708/EU/Developing and implementing a community-based intervention to create a more supportive social and physical environment for lifestyle changes to prevent diabetes in vulnerable families across Europe/Feel4Diabetes

Tipo y forma: Article (Published version)